Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
- PMID: 21429562
- PMCID: PMC3153604
- DOI: 10.1016/j.semarthrit.2011.01.002
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
Abstract
Objectives: To determine the prevalence, correlates, and predictors of work disability (WD) in the Genetics versus ENvironment In Scleroderma Outcome Study (GENISOS). We hypothesized that WD in systemic sclerosis (SSc) is a function of demographic, clinical, and psychosocial factors.
Methods: Patients enrolled in the GENISOS cohort were subdivided in 3 groups: work disabled, working, and retired or homemakers. The latter group (n = 29) was excluded from further analysis. We used logistic regression analysis with a forward hierarchical variable selection strategy to investigate the independent correlates of WD at enrollment. Cox regression proportional Hazard's model with a similar variable selection strategy was utilized to determine the predictors of WD in those working at enrollment.
Results: Overall, 284 patients with a mean age of 48.7 years and disease duration of 2.5 (±1.6) years were enrolled into the GENISOS cohort, consisting of 83.5% female, 46.8% white, 28.9% Hispanic, and 20.4% African American. Patients were longitudinally followed in 1438 study visits. At enrollment, 124 patients (43.7%) were work disabled, whereas 131 (46.1%) were working. Lower level of education (P < 0.001), higher Medsger Lung Severity Index (P = 0.012), higher Fatigue Severity Score (P = 0.008), and less social support (P < 0.001) correlated independently with WD. Of those working at baseline, 35 (26.7%) eventually developed WD. Non-white ethnicity (P = 0.038), lower DLCO % predicted value (P = 0.038), and higher Fatigue Severity Score (P = 0.009) at enrollment independently predicted WD on follow-up visits.
Conclusions: WD is a major problem among SSc patients and its prevalence is substantially higher than other rheumatic conditions. Demographic, clinical, and psychosocial factors correlate with WD cross-sectionally and predict WD longitudinally in these patients.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
References
-
- Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg. 1998 Mar;17(1):48–54. - PubMed
-
- Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005 Jan;118(1):2–10. - PubMed
-
- Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La MG, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002 Mar;81(2):139–53. - PubMed
-
- Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002 Mar;81(2):154–67. - PubMed
Publication types
MeSH terms
Grants and funding
- M01-RR01346/RR/NCRR NIH HHS/United States
- P50 AR054144/AR/NIAMS NIH HHS/United States
- N01 AR002251/AR/NIAMS NIH HHS/United States
- M01-RR00073/RR/NCRR NIH HHS/United States
- UL1 RR024148/RR/NCRR NIH HHS/United States
- UL1-RR024148/RR/NCRR NIH HHS/United States
- P50AR054144/AR/NIAMS NIH HHS/United States
- M01 RR001346/RR/NCRR NIH HHS/United States
- 5T32-AR052283-03/AR/NIAMS NIH HHS/United States
- T32 AR052283/AR/NIAMS NIH HHS/United States
- KL2 RR024149/RR/NCRR NIH HHS/United States
- KL2RR024149-04/RR/NCRR NIH HHS/United States
- M01 RR000073/RR/NCRR NIH HHS/United States
- TL1 RR024147/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical